Related Experiment Video

Updated: Jul 5, 2026

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

Immunohistochemical detection, regulation and antiproliferative function of G-protein-coupled receptor kinase 2 in

Thierry Métayé1, Pierre Levillain, Jean-Louis Kraimps

  • 1Biophysics Laboratory, CHU de Poitiers, BP 577, 86021 Poitiers Cedex, France. t.metaye@chu-poitiers.fr

The Journal of Endocrinology
|May 3, 2008
PubMed

Insights

Thyroid-stimulating hormone (TSH) promotes thyroid tumor growth. This study found that G-protein-coupled receptor kinase 2 (GRK2) unexpectedly inhibits thyroid cancer cell proliferation, revealing a new role for GRK2 in cancer.

Area of Science:

  • Endocrinology
  • Oncology
  • Molecular Biology

Background:

  • Thyroid-stimulating hormone (TSH) receptor signaling drives thyroid tumor growth.
  • The role of G-protein-coupled receptor kinase 2 (GRK2) in thyroid cancer is not well understood.

Purpose of the Study:

  • To investigate the expression and function of GRK2 in thyroid cancer.
  • To determine if GRK2 plays a role in thyroid cancer cell proliferation.

Main Methods:

  • Immunohistochemistry and Western blotting were used to analyze GRK2 expression in thyroid tissues and cell lines.
  • GRK2 expression was manipulated in thyroid cancer cell lines to assess its effect on proliferation.

Main Results:

  • GRK2 expression was significantly increased in various types of thyroid cancers compared to normal tissues.
  • Overexpression of GRK2 in thyroid cancer cell lines led to a marked reduction in cell proliferation (28-65% inhibition).

Conclusions:

  • TSH and other growth factors stimulate GRK2 accumulation in thyroid cells, potentially explaining elevated GRK2 in differentiated thyroid carcinoma.
  • GRK2 unexpectedly inhibits thyroid cancer cell proliferation, suggesting a novel tumor-suppressive role for this kinase.

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...